Shanghai InnoStar Bio-tech Co Osingo per osake

Mitä Shanghai InnoStar Bio-tech Co tekee? Shanghai InnoStar Bio-tech Co Ltd is a company based in Shanghai, China, operating within the Life Sciences Tools & Services sector of the Health Care industry. The company has 1,085 employees and completed its initial public offering (IPO) on September 3, 2024. It provides biopharmaceutical non-clinical research services, focusing on early drug development evaluation, non-clinical research, and clinical testing and translational research. The early drug development evaluation involves creating multiple early toxicity rapid prediction and screening models. Non-clinical research encompasses safety evaluation, pharmacokinetic research, and pharmacodynamic research. Clinical testing and translational research offers analytical methods and data support for clinical pharmacokinetics, efficacy, and safety studies related to innovative drug projects. The company's headquarters are located in Shanghai, and it maintains a website at www.innostar.cn. Its stock is listed under the ticker 688710.SS with ISIN CNE1000078J7. Shanghai InnoStar Bio-tech Co Ltd serves the biopharmaceutical sector by supporting the development and evaluation of new drugs through specialized research services. Shanghai InnoStar Bio-tech Co on yksi Eurpooliin suosituimmista yhtiöistä.